Table 4.
Hypoglycemia definition | Hypoglycemia at any time of day (24 h) | Nocturnal hypoglycemia (00:00–05:59 h) | ||
---|---|---|---|---|
Gla-300a
(N = 20) |
Gla-100a
(N = 20) |
Gla-300a
(N = 20) |
Gla-100a
(N = 20) |
|
Any hypoglycemia | ||||
Participants experiencing ≥1 event during the treatment period, n (%) | 17 (85.0) | 20 (100.0) | 4 (20.0) | 8 (40.0) |
Total number of events during the treatment period | 126 | 192 | 6 | 20 |
Confirmed (≤3.9 mmol L−1 [≤70 mg dL−1]) or severe hypoglycemiab | ||||
Participants experiencing ≥1 event during the treatment period, n (%) | 17 (85.0) | 20 (100.0) | 4 (20.0) | 8 (40.0) |
Total number of events during the treatment period | 126 | 189 | 6 | 20 |
Confirmed (<3.0 mmol L−1 [<54 mg dL−1]) or severe hypoglycemiab | ||||
Participants experiencing ≥1 event during the treatment period, n (%) | 8 (40.0) | 12 (60.0) | 1 (5.0) | 4 (20.0) |
Total number of events during the treatment period | 28 | 44 | 1 | 6 |
Gla-300 insulin glargine 300 U mL−1, Gla-100 insulin glargine 100 U mL−1
aData pooled from subgroups 1 and 2 by treatment
bConfirmed or severe hypoglycemia includes documented symptomatic, asymptomatic and severe hypoglycemia